Systemic Administration of siRNA with Anti-HB-EGF Antibody-Modified Lipid Nanoparticles for the Treatment of Triple-Negative Breast Cancer
Year: 2018
Type: article
Source: Molecular Pharmaceutics
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
Awards: Development of antibody-drug conjugate to diagnose and treat vulnerable plaque, Novel strategy of tumor treatiment via the normalization of tumor vasculature by microRNA, 腫瘍選択的核酸送達技術を用いたがん治療法の開発, Design of Synthetic Polymer Nanoparticles Specifically Capturing Indole for improvement of uremia symptom, Development of functional lipid nanoparticles for RNA interference-based therapy
OpenAlex ID: W2790069484
